-

Click Therapeutics to Present at the Cowen and Company 40th Annual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced that Ross Muken, Chief Financial Officer, will give a corporate presentation and will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference. The presentation will be at 8:30 a.m. ET and the panel will take place at 1:30 p.m. ET on Tuesday, March 3 at the Boston Marriott Copley Place.

Investors attending the conference who would like to schedule one-on-one meetings with Click executives can do so by contacting Ross Muken.

About Click Therapeutics
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults. For more information, visit www.ClickTherapeutics.com.

Contacts

Company Contact
Jonathan Sirota
Senior Associate, Corporate Finance
jsirota@clicktherapeutics.com

Media Contact
Karen Sharma
ksharma@macbiocom.com
781-235-3060

Click Therapeutics, Inc.


Release Summary
Click Therapeutics to Present at the Cowen and Company 40th Annual Healthcare Conference
Release Versions

Contacts

Company Contact
Jonathan Sirota
Senior Associate, Corporate Finance
jsirota@clicktherapeutics.com

Media Contact
Karen Sharma
ksharma@macbiocom.com
781-235-3060

More News From Click Therapeutics, Inc.

Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank

NEW YORK--(BUSINESS WIRE)--Click today announced that it has secured a $15 million term loan from Silicon Valley Bank....

Click Therapeutics to Present at Chardan’s Prescription Digital Therapeutics Summit

NEW YORK--(BUSINESS WIRE)--Click today announced that Randall Stanicky, CFO, will present at Chardan’s Prescription Digital Therapeutics Summit on April 11, 2022....

Click Therapeutics Announces Formation of Scientific Advisory Board of Experts in Healthcare and Technology

NEW YORK--(BUSINESS WIRE)--Click Therapeutics today announced the formation of a Scientific Advisory Board (SAB) of experts in healthcare and technology....
Back to Newsroom